Brief: Theratechnologies Announces FDA Approval Of Trogarzo

Theratechnologies

13/12/2023 12:44

Dec 13 (Reuters) - Theratechnologies Inc  TH.TO :
    * THERATECHNOLOGIES ANNOUNCES FDA APPROVAL OF TROGARZO®
90-SECOND
INTRAVENOUS (IV) PUSH LOADING DOSE
    * THERATECHNOLOGIES INC - UPDATED LABEL MEANS NEW
TROGARZO(®)
PATIENTS NO LONGER REQUIRE INITIATION OF TREATMENT BY 30-MINUTE
INFUSION
    * THERATECHNOLOGIES-COMPLETE IV PUSH METHOD ENABLES EASIER,
MORE
CONVENIENT ADMINISTRATION OF TROGARZO FOR HEAVILY
TREATMENT-EXPERIENCED ADULTS WITH HIV
    * THERATECHNOLOGIES INC - CURRENTLY FINALIZING ITS
APPLICATION TO
FDA FOR AN INTRAMUSCULAR (IM) METHOD OF ADMINISTRATION OF
TROGARZO(®) MAINTENANCE DOSE

Source text for Eikon:  ID:nGNX5ZhHrX 
Further company coverage:  TH.TO 

 ((Reuters.Briefs@thomsonreuters.com;))